General Biophysics LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersWayland, MA
SAM.gov UEIMTDKKELM58W5
General Biophysics develops xenon-based drug-device platforms and therapies for neurological disorders including neurodegeneration, opioid use disorder, and pain. The company uses xenon as a therapeutic agent that targets multiple mechanisms such as microglial activation, GSK3β signaling, glutamatergic excitotoxicity, ion channel activity, and neuroinflammation.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| General Biophysics LLC | Wayland | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


